Geographic Atrophy Overview
Learn About Geographic Atrophy
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Professional Services
Christina Flaxel is an Ophthalmologist in The Dalles, Oregon. Dr. Flaxel and is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. Her top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Vitrectomy. Dr. Flaxel is currently accepting new patients.
University Professional Services
Steven Bailey is an Ophthalmologist in Portland, Oregon. Dr. Bailey and is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Central Serous Chorioretinopathy, and Vitrectomy. Dr. Bailey is currently accepting new patients.
University Professional Services
Brandon Lujan is an Ophthalmologist in Portland, Oregon. Dr. Lujan and is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Vitrectomy, and Trabeculectomy. Dr. Lujan is currently accepting new patients.
Summary: This study is open to people 50 years or older with an eye condition called geographic atrophy. The purpose of this study is to compare a medicine called BI 771716 with a medicine called pegcetacoplan. BI 771716 is being developed to treat people with geographic atrophy. Pegcetacoplan is a medicine already used to treat people with geographic atrophy. In this study, participants receive either BI ...
Summary: A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration